MetLife Inc MET.N, MET is expected to show a rise in quarterly revenue when it reports results on February 5 for the period ending December 31 2024
The New York City-based company is expected to report a 4.2% increase in revenue to $19.504 billion from $18.72 billion a year ago, according to the mean estimate from 7 analysts, based on LSEG data. (Sales/ Revenue Majority Basis is on Total Adjusted Revenues)
LSEG's mean analyst estimate for MetLife Inc is for earnings of $2.10 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for MetLife Inc is $97.00, above its last closing price of $86.51.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | 2.19 | 2.17 | 1.95 | Missed | -10.1 |
Jun. 30 2024 | 2.09 | 2.10 | 2.28 | Beat | 8.4 |
Mar. 31 2024 | 1.81 | 1.81 | 1.83 | Beat | 0.9 |
Dec. 31 2023 | 1.90 | 1.89 | 1.93 | Beat | 2.1 |
Sep. 30 2023 | 1.94 | 1.94 | 1.95 | Beat | 0.6 |
Jun. 30 2023 | 1.85 | 1.87 | 1.94 | Beat | 3.8 |
Mar. 31 2023 | 1.68 | 1.83 | 1.52 | Missed | -16.9 |
Dec. 31 2022 | 1.62 | 1.65 | 1.55 | Missed | -5.9 |
This summary was machine generated February 3 at 21:30 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)